(Q39630106)

13 September 2017

Tissue plasminogen activator, plasminogen activator inhibitors, and activator-inhibitor complex in liver disease (English)

1 reference

13 September 2017

1 reference

Leiper K

1

1 reference

13 September 2017

Croll A

2

1 reference

13 September 2017

Booth NA

3

1 reference

13 September 2017

Moore NR

4

1 reference

13 September 2017

Sinclair T

5

1 reference

13 September 2017

Bennett B

6

1 reference

13 September 2017

language of work or name

English

0 references

publication date

1 March 1994

1 reference

Journal of Clinical Pathology

13 September 2017

1 reference

13 September 2017

47

1 reference

13 September 2017

3

1 reference

13 September 2017

214-217

1 reference

ABNORMAL PLASMINOGEN-PLASMIN SYSTEM ACTIVITY (FIBRINOLYSIS) IN PATIENTS WITH HEPATIC CIRRHOSIS: ITS CAUSE AND CONSEQUENCES.

13 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=501897

Plasminogen activators in alcoholic cirrhosis: demonstration of increased tissue type and urokinase type activator

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=501897

Plasminogen activator inhibitor (PAI-1) in plasma and platelets

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=501897

Alpha 2-plasmin inhibitor and its deficiency states

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=501897

The platelet and plasma pools of plasminogen activator inhibitor (PAI-1) vary independently in disease

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=501897

Hepatic synthesis and clearance of components of the fibrinolytic system in healthy volunteers and in patients with different stages of liver cirrhosis

15 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=501897

Clearance of t-PA, PAI-1, and t-PA-PAI-1 complex in an isolated perfused rat liver system

15 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=501897

The receptor for tissue plasminogen activator (t-PA) in complex with its inhibitor, PAI-1, on human hepatocytes

15 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=501897

A shift in balance between profibrinolytic and antifibrinolytic factors causes enhanced fibrinolysis in cirrhosis

15 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=501897

The bleeding disorder in acute promyelocytic leukaemia: fibrinolysis due to u-PA rather than defibrination

15 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=501897

Plasminogen activators and plasminogen activator inhibitors in liver deficiencies caused by chronic alcoholism or infectious hepatitis

21 August 2018

1 reference

12 December 2020

Plasminogen activator inhibitors (PAI-1 and PAI-2) in normal pregnancies, pre-eclampsia and hydatidiform mole

1 reference

12 December 2020

FIBRINOLYTIC ACTIVITY IN CIRRHOSIS OF THE LIVER

1 reference

12 December 2020

Antifibrinolytic activity in primary carcinoma of the liver

1 reference

12 December 2020

Reduced histidine-rich glycoprotein levels in plasma of patients with advanced liver cirrhosis. Possible implications for enhanced fibrinolysis

1 reference

12 December 2020

Hepatic clearance of tissue-type plasminogen activator in rats

1 reference

12 December 2020

The pathogenesis of accelerated fibrinolysis in liver cirrhosis: a critical role for tissue plasminogen activator inhibitor

1 reference

12 December 2020

Protease inhibitors in liver disease

1 reference

12 December 2020

Identifiers

DOI

10.1136/JCP.47.3.214

1 reference

13 September 2017

1 reference

13 September 2017

PubMed publication ID

8163691

1 reference